P
PhaseV
About
PhaseV develops a platform for adaptive trial design and closed-loop execution, leveraging an intuitive user interface and flexible software architecture along with cutting-edge algorithms such as reinforcement learning and causal ML to support key clinical decisions at any point during the trial
Tags
Total Employees
51
Current headcount
Company Timeline
Funding rounds, employee growth, revenue, and exits over the same period. News mentions shown as markers.
No timeline data for this period
Score Breakdown
44Traction
56Team
70Visibility
20Profile
80Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does PhaseV do?
PhaseV develops a platform for adaptive trial design and closed-loop execution, leveraging an intuitive user interface and flexible software architecture along with cutting-edge algorithms such as reinforcement learning and causal ML to support key clinical decisions at any point during the trial (formerly PhaseV Trials.)
How much funding has PhaseV raised?
PhaseV has raised a total of $65M in funding. The most recent round on record is Series A.
When was PhaseV founded?
PhaseV was founded in 2023.
What industry does PhaseV operate in?
PhaseV operates in Life Sciences, Clinical Trials, Optimization.
How many employees does PhaseV have?
PhaseV has approximately 51 people on record.